Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections treatment news

Show

From To
Testing times: four emerging STIs that you can’t afford to ignore

Although gonorrhoea, chlamydia and syphilis grab most of the headlines, public health officials are warily watching the emergence of other bacterial sexually transmitted infections.

Published
06 December 2018
From
Mosaic
How dangerous is gonorrhoea resistance and can it be halted?

The bacterium that causes the common sexually transmitted infection (STI) gonorrhoea develops resistance to antibiotics easily, and some cases of multidrug-resistant gonorrhoea, originating from abroad, were reported

Published
06 December 2018
By
Gus Cairns
Drug-resistance of gonorrhoea in the EU: persistent but stable

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP).

Published
04 September 2018
From
ECDC
'World's worst' super-gonorrhoea man cured

The patient had a lucky escape say doctors, but now two more cases have been discovered.

Published
23 April 2018
From
BBC Health
The recent trend towards multi-resistant gonorrhoea in coastal China

Alarming data have recent been reported (Yin & Chen) (Y&C) from the China Gonococcal Resistance Surveillance Programme (China-GRSP), covering seven (mostly coastal) provinces in the period 2013-2016. The study is relevant for Chinese national treatment policy, which currently recommends azithromycin monotherapy. However, with an estimated 45% of the world’s 78 million incident cases occurring in [...]Read More...

Published
29 March 2018
From
BMJ Group blogs
Drug-resistant gonorrhoea rates plummet in US

Preliminary results announced at the US 2014 STD Prevention Conference in Atlanta have shown that the proportion of cases of gonorrhoea that are drug-resistant has fallen since 2011,

Published
16 June 2014
By
Gus Cairns
HIV infection doesn't generally affect the response to syphilis treatment

Well-controlled HIV infection does not have a significant impact on the serological response to treatment for syphilis, Swiss investigators report in the online edition of Clinical Infectious

Published
18 September 2012
By
Michael Carter
Reduced susceptibility to first-line drug causes change in UK gonorrhoea prescribing practice

UK Prescribing guidance for the treatment of gonorrhoea needs to change because of increasing prevalence of bacteria with reduced susceptibility to the first-line antibiotic cefixime, the Health

Published
11 October 2011
By
Michael Carter
Herpes drugs and viral load: valaciclovir works better than aciclovir

The anti-herpes drug valaciclovir (Valtrex, valacyclovir in the US) produced a 17-fold (1.23 log) reduction in HIV viral load in Kenyan patients not taking treatment, the sixth

Published
26 July 2011
By
Gus Cairns
Daily aciclovir slows HIV disease progression and reduces viral load

Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the

Published
19 July 2011
By
Michael Carter
← First123Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.